[Use of T-activin and thymalin in the treatment of ophthalmic herpes].
Mal'khanov. V B VB; Gripas'. I A IA; Nasibullina. G Kh GKh; Belousova. M A MA
Key Findings
- Thymalin and T‑activin showed therapeutic benefit in ophthalmic herpes patients
- The peptides are especially recommended for prolonged (protracted) cases
- Neutrophil injury index and tear secretory IgA can be used to monitor treatment response
Practical Outcomes
- For biohackers, thymalin might be considered as an immune‑support supplement for viral eye issues, but the evidence is limited to a specific infection and does not directly translate to longevity or performance goals. Use caution, follow dosing guidelines from clinical sources, and monitor immune markers if experimenting.
Summary
A study on 80 people with eye herpes found that thymalin (a thymic hormone) and a related peptide called T‑activin helped treat the infection, especially when it lasts a long time. The researchers suggest checking immune markers like neutrophil damage and secretory IgA in tears to see how well the treatment works.
Abstract
Therapeutic efficacies of thymalin and T-activin were assessed in 80 patients with ophthalmic herpes. Thymic hormone preparations are recommended for the treatment of a protracted condition. To monitor the course of immunomodulating therapy, the neutrophil injury index and measurements of secretory IgA in the lacrimal fluid may be used, besides the routine tests.
Study Information
pubmed
1991